Project Grant HT94252510788
Award Date 9/30/25
Completion Date 9/29/29
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
- This $1,211,127 Project Grant awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports a research project by the University of California, San Francisco (UCSF) to investigate the importance of immune responses to prostate tumor antigens primed by a combination of radiation and immunotherapy. The 4-year project aims to advance understanding of how to leverage the body's immune system to improve treatments for prostate cancer. As...
- The U.S. Defense Health Agency awarded a $1,312,000.00 Project Grant to the Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective August 1, 2025 through July 31, 2029, supports research strategies to upregulate and image Nectin4 to enhance Nectin4-targeted therapies in bladder cancer. As a prominent academic medical center and research institution, UCSF will leverage its expertise in...
- The federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,967,999.00 in funding to The Regents of the University of California, San Francisco (UCSF) to develop a CD46 targeted antibody fragment radiopharmaceutical therapy for the treatment of prostate cancer. The award period runs from July 1, 2025 through June 30, 2028. This research aims to advance innovative medical solutions to address critical...
- The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,453,501.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) on June 1, 2024. The grant supports the development of "Targeted Theranostic Nanopolymers for Imaging and Alpha Radiopharmaceutical Therapy of Prostate Cancer" over a period of 3 years through May 31, 2027. As a leading academic medical center, UCSF will leverage its expertise in biomedical...
- The University of California, San Francisco (UCSF) has been awarded a $1,202,087 federal Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to investigate SSTR1 as a novel biomarker and therapeutic target in advanced prostate cancer. The award, effective July 1, 2024 through June 30, 2028, will enable UCSF researchers to conduct innovative scientific studies to develop new treatments for this challenging disease. As a leading academic...
- The Department of the Army Medical Command awarded a $161,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) to conduct research on "Deciphering Translational Control of Androgen Receptor in Prostate Cancer". The grant project will run from April 1, 2024 to March 31, 2026. As a leading academic medical center and research institution, UCSF has extensive expertise in federal...
- The Defense Health Agency awarded a $468,000 Project Grant to the University of California, Los Angeles under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research developing new therapeutic strategies to target TROP2 in aggressive prostate cancer. The two-year award beginning March 15, 2023 will fund research efforts to investigate medical solutions for prostate cancer on the battlefield and transform health care for service members and the public...
- The University of California, San Diego (UCSD) was awarded a $1,218,012 Project Grant from the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "GERMLINE INFLUENCE ON PROSTATE CANCER METASTASIS AND TREATMENT RESPONSE." The research aims to transform health care for Service Members and the American public by investigating medical solutions for the battlefield through innovative and impactful...
- This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,615,000.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research aimed at "DISCOVERING TRANSCRIPTIONAL DRIVERS OF THERAPY-RESISTANT METASTATIC PROSTATE CANCER". The award period runs from May 1, 2024 to April 30, 2027. As a leading academic medical center, UCSF has a strong track record of...